Related Experiment Videos
[Minimally invasive therapy for bladder and prostate cancer]
1Dept. of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|August 30, 2001
Summary
Minimally invasive therapies are advancing in urology for bladder and prostate cancers. Treatment selection requires careful consideration of individual patient needs, quality of life, and cost-effectiveness.
Area of Science:
- Urology
- Oncology
- Minimally Invasive Surgery
Context:
- Minimally invasive therapy is a significant development in urology.
- Numerous novel treatments are emerging for urological conditions.
Purpose:
- To review current minimally invasive therapeutic options for bladder and prostate cancer.
- To highlight the importance of personalized treatment selection.
Summary:
- Bacillus Calmette-Guerin (BCG) instillation, transurethral resection, and intra-arterial infusion with irradiation are minimally invasive treatments for bladder cancer.
- Laparoscopic prostatectomy, brachytherapy, 3D-CRT, and HIFU represent minimally invasive approaches for prostate cancer.
Impact:
- While the efficacy of these treatments is still under evaluation, personalized patient care is crucial.
- Treatment decisions should integrate patient quality of life and economic factors for optimal outcomes.